This post was originally published on this site
https://i-invdn-com.akamaized.net/news/1000px-3M_wordmark_M_1440048386.jpgInvesting.com – component 3M (NYSE:) slid in midday trading Monday following a sell-side downgrade citing litigation overhang concerns over perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Citi downgraded the stock to neutral from buy with a $180 price target.
Shares fell 0.5%.
“While we think MMM’s shorter-cycle end markets could be closer to a bottom and execution seems poised to improve, growing PFAS-litigation related risks could be a lingering overhang that prevents a re-rating to its former premium multiple,” Citi analyst Andrew Kaplowitz wrote.
3M (NYSE:) told Congress in September that it has not been established that PFAs cause health problems.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.